Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

To assess the safety and efficacy of rilpivirine in combination with emtricitabine and tenofovir (RPV/FTC/TDF) as a once-daily single-tablet regimen (STR) in HIV-1-infected children and adolescents we performed a multicenter case series study of HIV-1-infected patients. Inclusion criteria were initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcon-Neyra, Lola, Palladino, Claudia, Navarro Gómez, María Luisa, Soler-Palacín, Pere, González-Tomé, María Isabel, De Ory, Santiago J., Frick, Marie Antoinette, Fortuny, Clàudia, Noguera-Julian, Antoni, Moreno, Elena Bermúdez, Santos, Juan Luis, Olbrich, Peter, López-Cortés, Luis F., Briz, Verónica, Neth, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998448/
https://www.ncbi.nlm.nih.gov/pubmed/27310962
http://dx.doi.org/10.1097/MD.0000000000003842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998448/
https://www.ncbi.nlm.nih.gov/pubmed/27310962
http://dx.doi.org/10.1097/MD.0000000000003842

Ejemplares similares